Univest
Univest
  • Markets

Nifty Healthcare Prediction for Tomorrow, Tuesday 4 August 2026: Index at 40,512 as Defensive Buying and Strong Q1 Earnings Season Support

  • August 3, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments
Nifty Healthcare Prediction for Tomorrow, Tuesday 4 August 2026: Index at 40,512 as Defensive Buying and Strong Q1 Earnings Season Support

Nifty Healthcare Monday: 40,512 (+0.42%). Day range: 40,200-40,620. Support 40,200. Resistance 40,800-41,000. Nifty 50: 24,611 (+0.94%).

The Nifty Healthcare prediction for tomorrow for Tuesday 4 August 2026 is shaped by a historic macro event on Monday: US President Trump confirmed Iran-US peace negotiations, sending Brent crude crashing over 6 percent to $82 and lifting Nifty 50 by 228 points or 0.94 percent to 24,611.50, its first close above 24,600 in six weeks. Nifty Healthcare gained 0.42 percent Monday as defensive positioning attracted buyers amid high market-wide volatility from Iran developments. Healthcare stocks with strong Q1 FY27 earnings momentum provide fundamental support. Sun Pharma’s strong Q1 with 27 percent net profit growth set the bar high for the sector. The Nifty Healthcare prediction for tomorrow benefits from non-cyclical demand, a weakening dollar improving US generic drug pricing, and India’s domestic formulations market growing at 10-12 percent year-on-year. Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, present the full Nifty Healthcare prediction for tomorrow covering technical levels, key triggers and three stocks to watch.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Monday Session Data Behind the Nifty Healthcare Prediction For Tomorrow
  • Technical Levels for the Nifty Healthcare Prediction For Tomorrow
  • Key Factors for the Nifty Healthcare Prediction For Tomorrow
  • Stocks to Watch in the Nifty Healthcare Prediction For Tomorrow
  • Nifty Healthcare Prediction For Tomorrow: Trading Strategy
  • Risks to the Nifty Healthcare Prediction For Tomorrow
  • Conclusion
  • FAQs on Nifty Healthcare Prediction For Tomorrow
    • What is the Nifty Healthcare prediction for tomorrow, Tuesday 4 August 2026?
    • Which analysts prepared the Nifty Healthcare prediction for tomorrow?
    • How does the US dollar affect the Nifty Healthcare prediction for tomorrow?
    • What is Nifty Healthcare support and resistance for the prediction for tomorrow?
    • What stocks are watched in the Nifty Healthcare prediction for tomorrow?

Monday Session Data Behind the Nifty Healthcare Prediction For Tomorrow

Indicator Monday Change
Nifty Healthcare 40,512 +0.42%
Day Range 40,200-40,620 Session high/low
Nifty 50 24,611.50 +228 pts (+0.94%)
Bank Nifty 57,507.80 +531 pts (+0.93%)
India VIX 11.55 -4.9% (multi-month low)
FII Cash (provisional) +Rs 918 Cr Net Buyers

Technical Levels for the Nifty Healthcare Prediction For Tomorrow

Level Zone
Immediate Support 40,200
Support 2 39,800-39,900
Strong Support 39,200-39,300 (50 DMA)
Immediate Resistance 40,800-41,000
Key Resistance 41,300-41,500

Ankit Jaiswal notes that the Nifty Healthcare prediction for tomorrow rests on the immediate support at 40,200 holding during Tuesday’s session. Monday’s close near the session high for most assets confirms buyers were in control into the 3:30 PM bell, a strong quality signal for the Nifty Healthcare prediction for tomorrow. Kunal Singla adds that India VIX at 11.55, its lowest in several months, reduces the probability of a large gap-down reversal, providing a constructive technical environment for the Nifty Healthcare prediction for tomorrow.

Key Factors for the Nifty Healthcare Prediction For Tomorrow

  • Defensive characteristics of healthcare stocks attract buying during high market volatility events. Iran talk uncertainty on Monday made healthcare a preferred sector, supporting the Nifty Healthcare prediction for tomorrow.
  • Sun Pharma’s Q1 FY27 net profit jumped 27 percent with strong India business performance. This sets a positive earnings benchmark for the entire Nifty Healthcare prediction for tomorrow.
  • A softening US dollar at 95.59 improves rupee realizations for Indian generic drug exporters selling in the US market, the single largest export destination for Indian pharma companies in the Nifty Healthcare prediction for tomorrow.

Stocks to Watch in the Nifty Healthcare Prediction For Tomorrow

Univest analysts have flagged three stocks for educational observation in the Nifty Healthcare prediction for tomorrow. These are not buy recommendations.

1. Sun Pharma: Trading near Rs 1,778 on Monday. Ankit Jaiswal flags entry zone Rs 1,758-1,772, target Rs 1,828, stop loss Rs 1,730. Sun Pharma’s 27 percent Q1 net profit growth and strong India business make it the primary upside play in the Nifty Healthcare prediction for tomorrow.

2. Apollo Hospitals: Trading near Rs 7,215 on Monday. Kunal Singla flags entry zone Rs 7,150-7,200, target Rs 7,425, stop loss Rs 7,050. Apollo Hospitals represents domestic healthcare demand, insulated from export risks, making it a stable play in the Nifty Healthcare prediction for tomorrow.

3. Cipla: Trading near Rs 1,645 on Monday. Ankit Jaiswal flags entry zone Rs 1,625-1,640, target Rs 1,695, stop loss Rs 1,598. Cipla’s diversified portfolio across India, US generics and emerging markets provides broad healthcare sector exposure in the Nifty Healthcare prediction for tomorrow.

Use the Univest Screener to Find Strong Stocks for Tomorrow’s Session

Nifty Healthcare Prediction For Tomorrow: Trading Strategy

  1. 40,200 is the primary support for the Nifty Healthcare prediction for tomorrow.
  2. 40,800-41,000 is the immediate resistance for the Nifty Healthcare prediction for tomorrow. Ankit Jaiswal recommends booking here.
  3. Monitor Sun Pharma and Apollo Hospitals open prices for the first directional signal on the Nifty Healthcare prediction for tomorrow.
  4. Track any Q1 FY27 results from hospitals or diagnostics chains reporting Tuesday that could revise the Nifty Healthcare prediction for tomorrow.

Risks to the Nifty Healthcare Prediction For Tomorrow

  • Market-wide risk-on reducing defensive sector allocation to healthcare and limiting the Nifty Healthcare prediction for tomorrow gains.
  • USD/INR strengthening (dollar recovery) reducing export realizations for generic drug companies in the Nifty Healthcare prediction for tomorrow.
  • US FDA warning letters or import alerts on Indian manufacturing plants creating stock-specific downside in the Nifty Healthcare prediction for tomorrow.

Conclusion

The Nifty Healthcare prediction for tomorrow for Tuesday 4 August 2026 shows +0.42% to 40,512 on Monday, with India VIX at a multi-month low of 11.55 and FII returning to net buying at Rs 918 crore. Ankit Jaiswal of Univest identifies 40,800-41,000 as the key resistance for the Nifty Healthcare prediction for tomorrow while Kunal Singla considers 40,200 the most important support to watch Tuesday. Check GIFT Nifty at 9 AM IST, monitor Iran diplomatic updates overnight, and track Bharti Airtel and ONGC Q1 FY27 results in the first hour as the three most critical real-time inputs for the Nifty Healthcare prediction for tomorrow.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with NSE (nseindia.com), BSE (bseindia.com) and MCX (mcxindia.com) before investing. Investments are subject to market risk. Educational content only, not investment advice by Univest (SEBI RA INH000013776).

Download the Univest iOS App or Univest Android App for live market data and daily research from SEBI registered analysts.

FAQs on Nifty Healthcare Prediction For Tomorrow

What is the Nifty Healthcare prediction for tomorrow, Tuesday 4 August 2026?

Ans. The Nifty Healthcare prediction for tomorrow is mildly bullish. Nifty Healthcare closed Monday at 40,512, up 0.42 percent, supported by defensive buying and strong Q1 earnings from Sun Pharma. Support is 40,200 and resistance 40,800-41,000 in the Nifty Healthcare prediction for tomorrow.

Which analysts prepared the Nifty Healthcare prediction for tomorrow?

Ans. Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director at Univest, prepared the Nifty Healthcare prediction for tomorrow.

How does the US dollar affect the Nifty Healthcare prediction for tomorrow?

Ans. A softer US dollar at 95.59 improves rupee realizations for Indian generic drug exporters. Each 1 percent dollar weakening improves US-India pharma company revenues by approximately 0.8-1 percent in rupee terms, which is a tailwind for the Nifty Healthcare prediction for tomorrow.

What is Nifty Healthcare support and resistance for the prediction for tomorrow?

Ans. Support is 40,200 and 39,800-39,900. The 50 DMA at 39,200-39,300 is the medium-term floor. Resistance is 40,800-41,000 and 41,300-41,500 in the Nifty Healthcare prediction for tomorrow.

What stocks are watched in the Nifty Healthcare prediction for tomorrow?

Ans. Sun Pharma (strongest Q1 earnings in sector), Apollo Hospitals (domestic demand insulation) and Cipla (diversified portfolio) are the three stocks in the Nifty Healthcare prediction for tomorrow.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply